Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational Results available

Prospective Evaluation of Open Irrigated Ablation Catheters With High Resolution Mapping to Treat Paroxysmal Atrial Fibrillation

ClinicalTrials.gov ID: NCT03729830

Public ClinicalTrials.gov record NCT03729830. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 10:40 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To obtain data for the Rhythmia™ Mapping System in conjunction with Boston Scientific Open-Irrigated (OI) Catheters for ablation of Paroxysmal Atrial Fibrillation (PAF) according to current international and local guidelines. Primary objective: To assess acute and long-term outcomes for the Rhythmia Mapping System in conjunction with Boston Scientific Open-Irrigated Ablation Catheters to treat de novo Paroxysmal Atrial Fibrillation. De Novo PAF is defined as subjects undergoing first ablation procedure for PAF with no prior left atrial ablation (RF, Cryo, Surgical).

Study identification

NCT ID
NCT03729830
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Boston Scientific Corporation
Industry
Enrollment
415 participants

Conditions and interventions

Eligibility (public fields only)

Age range
20 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 4, 2019 (Actual)
Primary completion
May 3, 2024 (Actual)
Completion
May 3, 2024 (Actual)
Last update posted
Jan 21, 2026

2019 – 2024

United States locations

U.S. sites
18
U.S. states
12
U.S. cities
18
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35294 —
Torrance Memorial Medical Center Torrance California 90505 —
Broward General Medical Center Miami Florida 33136 —
AdventHealth Orlando Orlando Florida 32803 —
St. Lukes Idaho Cardiology Associates Boise Idaho 83712 —
University of Chicago Hospital Chicago Illinois 60637 —
St. John's Hospital Springfield Illinois 62769 —
University of Iowa Hospitals and Clinics Iowa City Iowa 52242 —
Nebraska Heart Institute Lincoln Nebraska 68526 —
Dartmouth Hitchcock Medical Center Lebanon New Hampshire 03756-1000 —
Catholic Medical Center Manchester New Hampshire 03102 —
Kaleida Health Buffalo New York 14213 —
Bethesda North Hospital Cincinnati Ohio 45220 —
Cleveland Clinic Foundation Cleveland Ohio 44195 —
Lehigh Valley Hospital Allentown Pennsylvania 18103 —
HeartPlace Mid-Cities EP Bedford Texas 76021 —
Orion Medical Pasadena Texas 77505 —
Christus Trinity Mother Frances Health System Tyler Texas 75701 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03729830, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 21, 2026 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03729830 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →